MedDataX Logo

The Influence of Oxytocin on the Processing of Social Contact

NCT ID: NCT01939639

Last Updated: 2013-09-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-03-31

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Social touch can convey the most potent and salient of socio-emotional signals. While the hypothalamic peptide oxytocin (OXT) has been identified as a key neurochemical mediator of grooming in some other social species, its modulatory influence on human interpersonal touch is unknown. The investigators expect that OXT augments the hedonic value of touch and that this behavioral effect is paralleled at the neural level by an increased response in brain areas mediating rewarding aspects of social touch.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Male Volunteers

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Oxytocin fMRI

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oxytocin

24 IU Oxytocin, intranasal application 30 min prior to the experiment

Group Type EXPERIMENTAL

Oxytocin

Intervention Type DRUG

24 IU Oxytocin, intranasal application 45 min prior to the experiment

Placebo

intranasal application, sodium chloride solution, 3 puffs per nostril

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

intranasal application, sodium chloride solution, 3 puffs per nostril

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo

intranasal application, sodium chloride solution, 3 puffs per nostril

Intervention Type DRUG

Oxytocin

24 IU Oxytocin, intranasal application 45 min prior to the experiment

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Syntocinon

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Healthy male volunteers

Exclusion Criteria

Current or past psychiatric disease Current or past physical illness Psychoactive medication Tobacco smokers
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Bonn

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rene Hurlemann

MD PhD M.Sc.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Psychiatry, University of Bonn

Bonn, North Rhine-Westphalia, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Related Links

Access external resources that provide additional context or updates about the study.

http://renehurlemann.squarespace.com/welcome/

Related Info

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PS_2013

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

OXT_PS_2013

Identifier Type: -

Identifier Source: org_study_id